相似文献
1
Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock.新冠疫情后的糖尿病远程医疗：覆水难收，时光难返。
J Diabetes Sci Technol. 2020 Jul;14(4):741-742. doi: 10.1177/1932296820932958. Epub 2020 Jun 6.
2
A Pandemic Forces United States to Leap Forward.一场大流行病迫使美国向前跃进。
J Diabetes Sci Technol. 2020 Jul;14(4):710-711. doi: 10.1177/1932296820929412. Epub 2020 Jun 2.
3
COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil.新冠疫情促使巴西出台远程医疗监管政策并加速糖尿病管理技术的应用。
J Diabetes Sci Technol. 2020 Jul;14(4):797-798. doi: 10.1177/1932296820930033. Epub 2020 Jun 2.
4
The COVID-19 Pandemic: A "Tech"-tonic Shift Toward Virtual Diabetes Care.新冠疫情：向虚拟糖尿病护理的“技术”巨变。
J Diabetes Sci Technol. 2020 Jul;14(4):708-709. doi: 10.1177/1932296820929719. Epub 2020 May 25.
5
Time for a Change: Personal Experiences With COVID-19 and Diabetes.变革之时：新冠病毒疾病与糖尿病的个人经历
J Diabetes Sci Technol. 2020 Jul;14(4):716-717. doi: 10.1177/1932296820928083. Epub 2020 May 22.
6
COVID-19 and Diabetes: Could Diabetes Technology Research Help Pave the Way for Remote Healthcare?2019冠状病毒病与糖尿病：糖尿病技术研究能否为远程医疗铺平道路？
J Diabetes Sci Technol. 2020 Jul;14(4):735-736. doi: 10.1177/1932296820929714. Epub 2020 May 30.
7
The COVID-19 Pandemic Revealed the Importance and Shortcomings of Technologies for Diabetes Support.
J Diabetes Sci Technol. 2020 Jul;14(4):712-713. doi: 10.1177/1932296820929721. Epub 2020 May 27.
8
Teleconsultation and Diabetes Care Amid COVID-19 Pandemic in India: Scopes and Challenges.印度新冠疫情期间的远程医疗与糖尿病护理：范围与挑战
J Diabetes Sci Technol. 2020 Jul;14(4):714-715. doi: 10.1177/1932296820929391. Epub 2020 May 21.
9
Some Lessons Learned About Diabetes and COVID-19 During the Early Stage of the Epidemic in Norway.挪威疫情早期关于糖尿病与新冠疫情的一些经验教训
J Diabetes Sci Technol. 2020 Jul;14(4):718-719. doi: 10.1177/1932296820929371. Epub 2020 May 26.
10
International Diabetes Center: COVID-19 Won't Stop Us From Fulfilling Our Mission.国际糖尿病中心：新冠疫情无法阻止我们履行使命。
J Diabetes Sci Technol. 2020 Jul;14(4):725-726. doi: 10.1177/1932296820927410. Epub 2020 May 14.
引用本文的文献
1
Contents and sentiment analysis of newspaper articles and comments on telemedicine in Korea: Before and after of COVID-19 outbreak.韩国报纸文章和评论中关于远程医疗的内容和情感分析：COVID-19 爆发前后。
Health Informatics J. 2022 Jan-Mar;28(1):14604582221075549. doi: 10.1177/14604582221075549.
2
Pedagogy and innovative care tenets in COVID-19 pandemic: An enhancive way through Dentistry 4.0.新冠疫情中的教学法与创新护理原则：通过牙科4.0的一种强化方式
Sens Int. 2021;2:100118. doi: 10.1016/j.sintl.2021.100118. Epub 2021 Jul 24.
3
Six Digital Health Technologies That Will Transform Diabetes.六种将改变糖尿病的数字健康技术。
J Diabetes Sci Technol. 2023 Jan;17(1):239-249. doi: 10.1177/19322968211043498. Epub 2021 Sep 24.
4
The Impact of COVID-19 Lockdown on Diabetes Complication and Diabetes Management in People With Diabetes in Indonesia.《COVID-19 封锁对印度尼西亚糖尿病患者糖尿病并发症和糖尿病管理的影响》。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211044888. doi: 10.1177/21501327211044888.
5
Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan.在日本 2019 冠状病毒病疫情紧急状态期间，通过远程医疗或门诊就诊进行的糖尿病管理改善了血糖控制。
J Diabetes Investig. 2022 Feb;13(2):386-390. doi: 10.1111/jdi.13546. Epub 2021 Apr 8.
6
The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications.沙特阿拉伯2019年冠状病毒病大流行期间远程医疗对2型糖尿病控制不佳患者的影响：研究结果与启示
J Telemed Telecare. 2023 Jun;29(5):390-398. doi: 10.1177/1357633X20985763. Epub 2021 Feb 1.
7
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.如何最佳保护糖尿病患者免受SARS-CoV-2的影响：国际COVID-19与糖尿病峰会报告
J Diabetes Sci Technol. 2021 Mar;15(2):478-514. doi: 10.1177/1932296820978399. Epub 2021 Jan 21.
8
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown.新冠疫情封锁期间 1 型糖尿病患者远程医疗的疗效。
Nutr Diabetes. 2021 Jan 5;11(1):1. doi: 10.1038/s41387-020-00147-8.
9
Pharmacoadherence: An Opportunity for Digital Health to Inform the Third Dimension of Pharmacotherapy for Diabetes.药物依从性：数字健康为糖尿病治疗的第三维度提供信息的机会。
J Diabetes Sci Technol. 2021 Jan;15(1):177-183. doi: 10.1177/1932296820973185. Epub 2020 Dec 8.
10
Evaluating the usability and safety of the semaglutide single-dose pen-injectors through summative (human factors) usability testing.通过总结性（人为因素）可用性测试来评估司美格鲁肽单次笔型注射器的可用性和安全性。
J Diabetes Investig. 2021 Jun;12(6):978-987. doi: 10.1111/jdi.13429. Epub 2020 Nov 18.
本文引用的文献
1
International Diabetes Center: COVID-19 Won't Stop Us From Fulfilling Our Mission.国际糖尿病中心：新冠疫情无法阻止我们履行使命。
J Diabetes Sci Technol. 2020 Jul;14(4):725-726. doi: 10.1177/1932296820927410. Epub 2020 May 14.
Zotero 插件